Daniele Lorenzini

Milan, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications

Assessing in house comprehensive genomic profiling by liquid biopsy for NSCLC patients.

Assessing in house comprehensive genomic profiling by liquid biopsy for NSCLC patients.

Journal: Tumori
Published: June 24, 2026

Hodgkin Reed-Sternberg Cells of Classic Hodgkin Lymphoma: Morphology, Phenotype, Genotype, and Cell of Origin.

Hodgkin Reed-Sternberg Cells of Classic Hodgkin Lymphoma: Morphology, Phenotype, Genotype, and Cell of Origin.

Journal: Cancers
Published: March 26, 2026

Leveraging Landmark Analysis for Tailored Surveillance in Stage I Non-Small-Cell Lung Cancer.

Leveraging Landmark Analysis for Tailored Surveillance in Stage I Non-Small-Cell Lung Cancer.

Journal: Cancers
Published: January 13, 2026

RAG1/2 expression in IGH-switched follicular lymphoma associated with transformation to high-grade B-cell lymphoma.

RAG1/2 expression in IGH-switched follicular lymphoma associated with transformation to high-grade B-cell lymphoma.

Journal: Leukemia
Published: December 09, 2025

Actionable Genomic Alterations in Large Cell Neuroendocrine Carcinoma: A European Case Series of Patients Treated With a Small Molecule Inhibitor.

Actionable Genomic Alterations in Large Cell Neuroendocrine Carcinoma: A European Case Series of Patients Treated With a Small Molecule Inhibitor.

Journal: JCO precision oncology
Published: November 14, 2025

Breast cancer and large-cell neuroendocrine carcinoma harboring the same PIK3CA mutation: A case report.

Breast cancer and large-cell neuroendocrine carcinoma harboring the same PIK3CA mutation: A case report.

Journal: Tumori
Published: July 16, 2025

Biomarker testing implementation for molecularly targeted therapy in non-small cell lung cancer patients.

Biomarker testing implementation for molecularly targeted therapy in non-small cell lung cancer patients.

Journal: Tumori
Published: July 10, 2025

Validating HER2 copy number variation assessment by NGS: A comparative analysis with immunohistochemistry and in situ hybridization.

Validating HER2 copy number variation assessment by NGS: A comparative analysis with immunohistochemistry and in situ hybridization.

Journal: Tumori
Published: July 09, 2025

Real-World Outcomes of Molecular Tumor Board Treatment Recommendations.

Real-World Outcomes of Molecular Tumor Board Treatment Recommendations.

Journal: JCO precision oncology
Published: June 11, 2025

Genomic instability and CCNE1 amplification as emerging biomarkers for stratifying high-grade serous ovarian cancer.

Genomic instability and CCNE1 amplification as emerging biomarkers for stratifying high-grade serous ovarian cancer.

Journal: Frontiers in oncology
Published: May 22, 2025

Impact of comprehensive genomic profiling and molecular tumour board on costs and access to tailored therapies: real-world observational study.

Impact of comprehensive genomic profiling and molecular tumour board on costs and access to tailored therapies: real-world observational study.

Journal: BMJ open
Published: May 16, 2025

Intracranial extranodal marginal zone lymphoma mimicking meningioma: A rare but insidious entity.

Intracranial extranodal marginal zone lymphoma mimicking meningioma: A rare but insidious entity.

Journal: Neuro-oncology advances
Published: May 05, 2025
Showing 1-12 of 56

Last Updated: 09/26/2026